BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 1331166)

  • 1. Pulsatile human corticotropin-releasing hormone prevents dexamethasone-induced suppression of the plasma cortisol response to hypoglycemia in normal men.
    Avgerinos PC; Kiamouris CK; Petrakos IP; Kleanthous IK; Zorzos PA; Dimitriadis TN; Raptis SA; Cutler GB
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1358-61. PubMed ID: 1331166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone.
    Reincke M; Allolio B; Würth G; Winkelmann W
    J Clin Endocrinol Metab; 1993 Jul; 77(1):151-6. PubMed ID: 8392081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The corticotropin-releasing hormone test in normal short children: comparison of plasma adrenocorticotropin and cortisol responses to human corticotropin-releasing hormone and insulin-induced hypoglycemia.
    Goji K
    Acta Endocrinol (Copenh); 1989 Mar; 120(3):390-4. PubMed ID: 2538990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-lipotropin/adrenocorticotropic hormone responses to corticotropin releasing hormone, hypoglycemia, metyrapone and dexamethasone in normal human subjects.
    Castro M; Moreira AC
    Braz J Med Biol Res; 1990; 23(11):1107-15. PubMed ID: 1966779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response effects of exogenous pulsatile human corticotropin-releasing hormone on adrenocorticotropin, cortisol, and gonadotropin concentrations in agonadal women.
    Thomas MA; Rebar RW; LaBarbera AR; Pennington EJ; Liu JH
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1249-54. PubMed ID: 1851183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ovine corticotropin-releasing hormone administered during insulin-induced hypoglycemia on plasma adrenocorticotropin and cortisol.
    DeCherney GS; DeBold CR; Jackson RV; Sheldon WR; Kamilaris TC; Island DP; Orth DN
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1211-8. PubMed ID: 3033009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of repeated human corticotropin-releasing hormone administration on dexamethasone-suppressed pituitary-adrenocortical activity in healthy subjects.
    Wiedemann K; Holsboer F
    Biol Psychiatry; 1997 Nov; 42(10):882-8. PubMed ID: 9359973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulsatile administration of human corticotropin-releasing hormone in patients with secondary adrenal insufficiency: restoration of the normal cortisol secretory pattern.
    Avgerinos PC; Schürmeyer TH; Gold PW; Tomai TP; Loriaux DL; Sherins RJ; Cutler GB; Chrousos GP
    J Clin Endocrinol Metab; 1986 May; 62(5):816-21. PubMed ID: 3007554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
    Dorin RI; Ferries LM; Roberts B; Qualls CR; Veldhuis JD; Lisansky EJ
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation by peptide histidine methionine (PHM) of adrenocorticotropin secretion in patients with Cushing's disease: a comparison with the effect of vasoactive intestinal peptide (VIP) and a study on the effect of combined administration of corticotropin-releasing hormone with PHM or VIP.
    Watanobe H; Tamura T
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1372-7. PubMed ID: 8200939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of the hypothalamic-pituitary-adrenal axis is altered by aging and exposure to social stress in female rhesus monkeys.
    Gust DA; Wilson ME; Stocker T; Conrad S; Plotsky PM; Gordon TP
    J Clin Endocrinol Metab; 2000 Jul; 85(7):2556-63. PubMed ID: 10902808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of a role of the hypothalamic-pituitary-adrenal axis in the fasting-induced suppression of luteinizing hormone secretion in adult male rhesus monkeys (Macaca mulatta).
    Helmreich DL; Mattern LG; Cameron JL
    Endocrinology; 1993 Jun; 132(6):2427-37. PubMed ID: 8389280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenergic modulation of adrenocorticotropin responses to insulin-induced hypoglycemia and corticotropin-releasing hormone.
    Tomori N; Suda T; Nakagami Y; Tozawa F; Sumitomo T; Ushiyama T; Demura H; Shizume K
    J Clin Endocrinol Metab; 1989 Jan; 68(1):87-93. PubMed ID: 2535853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of adrenocorticotropin (ACTH) stimulation tests and insulin hypoglycemia in normal humans: low dose, standard high dose, and 8-hour ACTH-(1-24) infusion tests.
    Nye EJ; Grice JE; Hockings GI; Strakosch CR; Crosbie GV; Walters MM; Jackson RV
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3648-55. PubMed ID: 10523009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An assessment of hypothalamo-pituitary-adrenal axis functioning in non-depressed, early abstinent alcoholics.
    Costa A; Bono G; Martignoni E; Merlo P; Sances G; Nappi G
    Psychoneuroendocrinology; 1996 Apr; 21(3):263-75. PubMed ID: 8817725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Function of the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain.
    Griep EN; Boersma JW; Lentjes EG; Prins AP; van der Korst JK; de Kloet ER
    J Rheumatol; 1998 Jul; 25(7):1374-81. PubMed ID: 9676772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
    Laue L; Chrousos GP; Loriaux DL; Barnes K; Munson P; Nieman L; Schaison G
    J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.